annual FCF:
-$604.32M-$273.69M(-82.78%)Summary
- As of today (September 10, 2025), ARWR annual free cash flow is -$604.32 million, with the most recent change of -$273.69 million (-82.78%) on September 30, 2024.
- During the last 3 years, ARWR annual FCF has fallen by -$752.07 million (-509.03%).
- ARWR annual FCF is now -475.27% below its all-time high of $161.03 million, reached on September 30, 2019.
Performance
ARWR Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$152.08M-$606.84M(-133.44%)Summary
- As of today (September 10, 2025), ARWR quarterly free cash flow is -$152.08 million, with the most recent change of -$606.84 million (-133.44%) on June 30, 2025.
- Over the past year, ARWR quarterly FCF has dropped by -$22.22 million (-17.11%).
- ARWR quarterly FCF is now -133.44% below its all-time high of $454.76 million, reached on March 31, 2025.
Performance
ARWR quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$17.62M-$22.22M(-483.40%)Summary
- As of today (September 10, 2025), ARWR TTM free cash flow is -$17.62 million, with the most recent change of -$22.22 million (-483.40%) on June 30, 2025.
- Over the past year, ARWR TTM FCF has increased by +$514.36 million (+96.69%).
- ARWR TTM FCF is now -110.54% below its all-time high of $167.24 million, reached on June 30, 2021.
Performance
ARWR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
ARWR Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.8% | -17.1% | +96.7% |
| 3 y3 years | -509.0% | -94.0% | +85.3% |
| 5 y5 years | -475.3% | -327.6% | +80.1% |
ARWR Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -509.0% | at low | -133.4% | +18.4% | -483.4% | +97.1% |
| 5 y | 5-year | -475.3% | at low | -133.4% | +18.4% | -110.5% | +97.1% |
| alltime | all time | -475.3% | at low | -133.4% | +18.4% | -110.5% | +97.1% |
ARWR Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$152.08M(-133.4%) | -$17.62M(-483.4%) |
| Mar 2025 | - | $454.76M(-386.4%) | $4.60M(-100.8%) |
| Dec 2024 | - | -$158.79M(-1.7%) | -$576.61M(-4.6%) |
| Sep 2024 | -$604.32M(+82.8%) | -$161.50M(+24.4%) | -$604.32M(+13.6%) |
| Jun 2024 | - | -$129.87M(+2.7%) | -$531.98M(+13.1%) |
| Mar 2024 | - | -$126.45M(-32.2%) | -$470.16M(+16.8%) |
| Dec 2023 | - | -$186.50M(+109.2%) | -$402.70M(+21.8%) |
| Sep 2023 | -$330.63M(+75.0%) | -$89.16M(+31.0%) | -$330.63M(-3.6%) |
| Jun 2023 | - | -$68.05M(+15.4%) | -$342.84M(-2.9%) |
| Mar 2023 | - | -$58.98M(-48.5%) | -$353.17M(+49.5%) |
| Dec 2022 | - | -$114.43M(+12.9%) | -$236.21M(+25.0%) |
| Sep 2022 | -$188.91M(-227.9%) | -$101.38M(+29.3%) | -$188.91M(+57.6%) |
| Jun 2022 | - | -$78.38M(-235.2%) | -$119.85M(+59.8%) |
| Mar 2022 | - | $57.98M(-186.4%) | -$75.00M(-160.6%) |
| Dec 2021 | - | -$67.13M(+107.7%) | $123.72M(-16.2%) |
| Sep 2021 | $147.75M(-237.1%) | -$32.32M(-3.7%) | $147.66M(-11.7%) |
| Jun 2021 | - | -$33.54M(-113.1%) | $167.24M(+1.2%) |
| Mar 2021 | - | $256.71M(-694.3%) | $165.21M(-234.7%) |
| Dec 2020 | - | -$43.19M(+239.2%) | -$122.69M(+14.3%) |
| Sep 2020 | -$107.75M(-166.9%) | -$12.73M(-64.2%) | -$107.34M(+21.1%) |
| Jun 2020 | - | -$35.57M(+14.0%) | -$88.63M(+93.7%) |
| Mar 2020 | - | -$31.19M(+12.0%) | -$45.76M(+33.2%) |
| Dec 2019 | - | -$27.85M(-565.8%) | -$34.36M(-121.3%) |
| Sep 2019 | $161.03M(-431.0%) | $5.98M(-18.1%) | $161.03M(+6.2%) |
| Jun 2019 | - | $7.30M(-136.9%) | $151.66M(+16.9%) |
| Mar 2019 | - | -$19.80M(-111.8%) | $129.75M(-3.0%) |
| Dec 2018 | - | $167.55M(-5042.7%) | $133.73M(-374.9%) |
| Sep 2018 | -$48.64M(+52.7%) | -$3.39M(-76.8%) | -$48.64M(-10.9%) |
| Jun 2018 | - | -$14.61M(-7.7%) | -$54.57M(+5.9%) |
| Mar 2018 | - | -$15.82M(+6.7%) | -$51.53M(+0.3%) |
| Dec 2017 | - | -$14.83M(+59.2%) | -$51.39M(+61.3%) |
| Sep 2017 | -$31.86M(-53.3%) | -$9.31M(-19.5%) | -$31.86M(-10.1%) |
| Jun 2017 | - | -$11.57M(-26.2%) | -$35.44M(-17.3%) |
| Mar 2017 | - | -$15.68M(-433.4%) | -$42.87M(+2.0%) |
| Dec 2016 | - | $4.70M(-136.5%) | -$42.03M(-38.5%) |
| Sep 2016 | -$68.29M(+0.9%) | -$12.89M(-32.1%) | -$68.29M(+0.1%) |
| Jun 2016 | - | -$19.00M(+28.0%) | -$68.25M(+8.9%) |
| Mar 2016 | - | -$14.84M(-31.1%) | -$62.65M(-2.8%) |
| Dec 2015 | - | -$21.55M(+67.7%) | -$64.48M(-4.7%) |
| Sep 2015 | -$67.68M(+82.3%) | -$12.86M(-4.1%) | -$67.68M(+2.2%) |
| Jun 2015 | - | -$13.40M(-19.6%) | -$66.21M(+4.7%) |
| Mar 2015 | - | -$16.67M(-32.7%) | -$63.23M(+15.5%) |
| Dec 2014 | - | -$24.75M(+117.4%) | -$54.75M(+47.4%) |
| Sep 2014 | -$37.13M(+92.1%) | -$11.39M(+9.3%) | -$37.13M(+18.8%) |
| Jun 2014 | - | -$10.42M(+27.2%) | -$31.25M(+18.7%) |
| Mar 2014 | - | -$8.19M(+14.7%) | -$26.32M(+16.4%) |
| Dec 2013 | - | -$7.14M(+29.8%) | -$22.62M(+17.0%) |
| Sep 2013 | -$19.33M(+22.2%) | -$5.50M(+0.1%) | -$19.33M(+4.5%) |
| Jun 2013 | - | -$5.50M(+22.4%) | -$18.51M(+8.8%) |
| Mar 2013 | - | -$4.49M(+16.7%) | -$17.02M(+0.7%) |
| Dec 2012 | - | -$3.85M(-17.7%) | -$16.89M(+6.8%) |
| Sep 2012 | -$15.82M | -$4.67M(+16.7%) | -$15.82M(+23.5%) |
| Jun 2012 | - | -$4.01M(-8.2%) | -$12.81M(+31.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.36M(+57.3%) | -$9.77M(+8.4%) |
| Dec 2011 | - | -$2.77M(+66.9%) | -$9.02M(+17.6%) |
| Sep 2011 | -$5.40M(-29.9%) | -$1.66M(+71.3%) | -$7.67M(-10.2%) |
| Jun 2011 | - | -$970.80K(-73.1%) | -$8.54M(-8.6%) |
| Mar 2011 | - | -$3.61M(+153.5%) | -$9.34M(+24.4%) |
| Dec 2010 | - | -$1.42M(-43.9%) | -$7.51M(-2.5%) |
| Sep 2010 | -$7.70M(-49.7%) | -$2.54M(+43.1%) | -$7.70M(+1.6%) |
| Jun 2010 | - | -$1.77M(-0.1%) | -$7.58M(+3.8%) |
| Mar 2010 | - | -$1.78M(+9.7%) | -$7.30M(-22.8%) |
| Dec 2009 | - | -$1.62M(-33.0%) | -$9.46M(-38.2%) |
| Sep 2009 | -$15.32M(-45.8%) | -$2.42M(+61.5%) | -$15.32M(-28.6%) |
| Jun 2009 | - | -$1.50M(-61.9%) | -$21.46M(-22.7%) |
| Mar 2009 | - | -$3.93M(-47.4%) | -$27.77M(-6.6%) |
| Dec 2008 | - | -$7.48M(-12.6%) | -$29.75M(+5.2%) |
| Sep 2008 | -$28.27M(+14.8%) | -$8.56M(+9.6%) | -$28.27M(+7.1%) |
| Jun 2008 | - | -$7.81M(+32.3%) | -$26.40M(+7.1%) |
| Mar 2008 | - | -$5.90M(-1.6%) | -$24.64M(-3.1%) |
| Dec 2007 | - | -$6.00M(-10.3%) | -$25.42M(+3.2%) |
| Sep 2007 | -$24.62M(+56.6%) | -$6.69M(+10.6%) | -$24.62M(+8.0%) |
| Jun 2007 | - | -$6.05M(-9.5%) | -$22.80M(+10.7%) |
| Mar 2007 | - | -$6.68M(+28.3%) | -$20.59M(+18.0%) |
| Dec 2006 | - | -$5.21M(+7.0%) | -$17.44M(+12.4%) |
| Sep 2006 | -$15.73M(+60.9%) | -$4.86M(+26.7%) | -$15.52M(+17.5%) |
| Jun 2006 | - | -$3.84M(+8.7%) | -$13.21M(+5.3%) |
| Mar 2006 | - | -$3.53M(+7.5%) | -$12.54M(+16.8%) |
| Dec 2005 | - | -$3.29M(+28.9%) | -$10.73M(+9.8%) |
| Sep 2005 | -$9.77M(+227.9%) | -$2.55M(-19.7%) | -$9.77M(+16.8%) |
| Jun 2005 | - | -$3.17M(+83.8%) | -$8.37M(+34.4%) |
| Mar 2005 | - | -$1.73M(-25.7%) | -$6.22M(+24.9%) |
| Dec 2004 | - | -$2.32M(+103.2%) | -$4.98M(+67.3%) |
| Sep 2004 | -$2.98M(+1765.9%) | -$1.14M(+11.2%) | -$2.98M(+54.0%) |
| Jun 2004 | - | -$1.03M(+111.3%) | -$1.93M(+111.9%) |
| Mar 2004 | - | -$486.90K(+52.1%) | -$913.00K(+96.8%) |
| Dec 2003 | - | -$320.20K(+225.4%) | -$464.00K(+190.5%) |
| Sep 2003 | -$159.70K(+48.6%) | -$98.40K(+1212.0%) | -$159.70K(+111.8%) |
| Jun 2003 | - | -$7500.00(-80.2%) | -$75.40K(-35.5%) |
| Mar 2003 | - | -$37.90K(+138.4%) | -$116.90K(+21.0%) |
| Dec 2002 | - | -$15.90K(+12.8%) | -$96.60K(-10.2%) |
| Sep 2002 | -$107.50K(+31.4%) | -$14.10K(-71.2%) | -$107.60K(-0.6%) |
| Jun 2002 | - | -$49.00K(+178.4%) | -$108.20K(+45.0%) |
| Mar 2002 | - | -$17.60K(-34.6%) | -$74.60K(-17.0%) |
| Dec 2001 | - | -$26.90K(+83.0%) | -$89.90K(+9.8%) |
| Sep 2001 | -$81.80K(+1.2%) | -$14.70K(-4.5%) | -$81.90K(-7.2%) |
| Jun 2001 | - | -$15.40K(-53.2%) | -$88.30K(-34.3%) |
| Mar 2001 | - | -$32.90K(+74.1%) | -$134.30K(+33.9%) |
| Dec 2000 | - | -$18.90K(-10.4%) | -$100.30K(+24.0%) |
| Sep 2000 | -$80.80K(+129.5%) | -$21.10K(-65.6%) | -$80.90K(-76.2%) |
| Jun 2000 | - | -$61.40K(-5681.8%) | -$340.60K(-543.5%) |
| Mar 2000 | - | $1100.00(+120.0%) | $76.80K(+1.5%) |
| Dec 1999 | - | $500.00(-100.2%) | $75.70K(+0.7%) |
| Sep 1999 | -$35.20K(<-9900.0%) | -$280.80K(-178.9%) | $75.20K(-78.9%) |
| Jun 1999 | - | $356.00K | $356.00K |
| Sep 1998 | $100.00(-97.8%) | - | - |
| Sep 1997 | $4600.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual free cash flow?
- What is the all time high annual FCF for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual FCF year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly FCF year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM FCF year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual free cash flow?
The current annual FCF of ARWR is -$604.32M
What is the all time high annual FCF for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual free cash flow is $161.03M
What is Arrowhead Pharmaceuticals, Inc. annual FCF year-on-year change?
Over the past year, ARWR annual free cash flow has changed by -$273.69M (-82.78%)
What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly FCF of ARWR is -$152.08M
What is the all time high quarterly FCF for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly free cash flow is $454.76M
What is Arrowhead Pharmaceuticals, Inc. quarterly FCF year-on-year change?
Over the past year, ARWR quarterly free cash flow has changed by -$22.22M (-17.11%)
What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow?
The current TTM FCF of ARWR is -$17.62M
What is the all time high TTM FCF for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM free cash flow is $167.24M
What is Arrowhead Pharmaceuticals, Inc. TTM FCF year-on-year change?
Over the past year, ARWR TTM free cash flow has changed by +$514.36M (+96.69%)